Skip to main content Skip to footer
Shared Investigator Platform

A new way forward

In light of the pandemic and technology breakthroughs such as AI and remote collaboration, life sciences organizations around the world are reconsidering how they conduct clinical trials.
Cognizant’s Shared Investigator Platform supports a new approach for streamlining clinical trials. As the industry’s first open, SaaS-based clinical ecosystem, Cognizant SIP connects sponsors, sites and technology providers working at home or other locations. It does so all from one place, with one sign-in.
Many leading life sciences companies have joined SIP, committing to a shared vision of common workflows, training and documents. Sponsors and sites report improved efficiencies and quicker study start-ups. The result? Faster time to market for new therapies—and more time helping patients.
Learn more about our Life Sciences solutions for your business.
Cognizant SIP Soars Past 300,000 Users

With over 300,000 users worldwide, Cognizant SIP’s remarkable journey continues.

BUSINESS INTELLIGENCE

Recently published insights

Today's new normal

Cognizant SIP for COVID-19

mountain

Related thinking

Accelerating clinical trials: The new and future normal

Accelerating clinical trials: The new and future normal

LIFE SCIENCES MANAGEMENT

Leadership

Kavitha Lokesh

VP, Head of LS R&D Delivery and Products and Platforms

Om Prakash

AVP Life Sciences, Head of Shared Investigator Platform

Vishal Janani

Product Manager, Cognizant Shared Investigator Platform

Lestter Cruz Serrano

Head of Medical Affairs, Shared Investigator Platform

Take the first step

Serving customers by looking forward as well as back is a big promise, but the power of today’s new digital capabilities is vast and growing.

Let’s talk about how digital can work for your business.